Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T15:01:31.846Z.
Calculation as of: 2026-10-06T15:01:31.846Z.
Quote observation: 2026-10-06T15:00:38.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 533c4696450707580a389d0c8167e09da333cd728c1767827588ef029f48caf5
PE RATIO
N/A
Market Cap
$597.83M
PE Ratio
4.73
TTM Avg
17.55
3Y Avg
51.19
5Y Avg
25.53
Market Cap
$568.99M
PE Ratio
N/A
TTM Avg
506.15
3Y Avg
506.15
5Y Avg
506.15
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | $605.01M | N/A | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.83M | 4.73 | 17.55 | 51.19 | 25.53 |
| Fulgent Genetics, Inc. (FLGT)vs › | $600.96M | N/A | 4.23 | 40.60 | 40.60 |
| OrthoPediatrics Corp. (KIDS)vs › | $582.66M | N/A | 419.02 | 415.26 | 415.26 |
| AngioDynamics, Inc. (ANGO)vs › | $610.07M | N/A | 43.31 | 43.31 | 89.76 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $568.99M | N/A | 506.15 | 506.15 | 506.15 |
| CorMedix Inc. (CRMD)vs › | $563.68M | 3.37 | 5.18 | 15.60 | 15.60 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $556.76M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $563.87M | N/A | 80.35 | 49.81 | 49.81 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$12.99
Forward EPS (Est.)
$-4.23
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
